The 7th International Conference on Pain & Chemical Dependency

描述（由申请人提供）： 国家药物滥用研究所（NIDA）的使命是利用科学的力量来应对药物滥用和成瘾;通过增加对疼痛管理的理解以及医疗保健提供者，政策制定者和治疗和/或研究疼痛的科学家之间疼痛管理和化学依赖性之间的关系，推进NIDA的使命。2004年举行的第六届国际疼痛和化学依赖性会议，登记了468名与会者。这些代表中有一半是医生，三分之一的与会者将疼痛管理作为他们的主要专业，另外三分之一专门从事成瘾医学和化学依赖。本次会议推进了2010年健康人的第一个目标，即提高健康生活的质量和年数，并实现临床预防保健目标1-6，即减少在获得保健方面遇到困难或延误或一名或多名家庭成员得不到所需保健的家庭比例。 第七届国际疼痛与化学依赖会议的特色主题包括一个国际论坛，重点关注对成瘾的恐惧及其对疼痛的影响、疼痛管理的临床方面、处方药滥用论坛、阿片类药物在非恶性疼痛中的使用、化学依赖性疼痛的管理、监管和伦理问题、以及一个基础科学论坛，重点是渴望的机制和疼痛和成瘾的遗传学。会议形式包括主题演讲与小组讨论，互动分组会议，案例研究和科学海报展示。贝斯以色列医疗中心（BIMC）和圣卢克罗斯福医院中心由继续医学教育认证理事会（ACCME）认证，并将认证第七届国际疼痛与化学依赖会议。与会者将有资格获得长达23小时的CME / CE学分。参加本次会议后，与会者将能够满足以下学习目标：讨论疼痛管理的国际观点，解释疼痛的遗传贡献和生理机制，解释成瘾的遗传贡献和生理机制，定义疼痛并列出疼痛评估的原则，定义成瘾并列出成瘾风险评估的原则，确定具体类型的疼痛和适当的治疗方法，描述最近的数据关于非甾体抗炎药和辅助镇痛药在治疗慢性疼痛，描述非恶性疼痛的治疗选择，讨论个性化疼痛管理的方法，特别是在有高成瘾风险或慢性非恶性疼痛等问题的患者中，并确定在监管环境中促进疼痛管理的行政程序。

DESCRIPTION (provided by applicant): The National Institute of Drug Abuse's (NIDA) mission is to bring the power of science to bear on drug abuse and addiction; The advances NIDA's mission by increasing understanding of pain management and the relationship between pain management and chemical dependency among healthcare providers, policy makers, and scientists who treat and/or research pain. The 6th International Conference on Pain & Chemical Dependency, held in 2004, registered 468 participants. One-half of these delegates were physicians with 1/3 of the attendees citing pain management as their primary specialty and an additional 1/3 specializing in addiction medicine and chemical dependency. This conference advances the first goal of Healthy People 2010, to increase the quality and years of healthy life and meets Clinical Preventive Care Objective 1-6 to reduce the proportion of families that experience difficulties or delays in obtaining health care or do not receive needed care for one or more family members. Featured topics of The 7th International Conference on Pain & Chemical Dependency include an international forum focusing on the fear of addiction and its impact on pain, the clinical aspects of pain management, a forum on prescription drug abuse, the use of opioids in nonmalignant pain, management of pain in the chemically dependent, regulatory and ethical issues, and a basic science forum focusing on mechanisms of craving and the genetics of pain and addiction. The conference format includes keynote lectures with panel discussions, interactive breakout sessions, case studies, and scientific poster presentations. Beth Israel Medical Center (BIMC) and St Luke's Roosevelt Hospital Center are accredited by the Accreditation Council for Continuing Medical Education (ACCME) and will certify The 7th International Conference on Pain & Chemical Dependency. Conference attendees will be eligible to earn up to 23 hours o CME / CE credit. After attending this conference, attendees will be able to meet the following learning objectives: discuss international perspectives on pain management, explain genetic contributions and physiologic mechanisms of pain, explain genetic contributions and physiologic mechanisms of addiction, define pain and list principles of pain assessment, define addiction and list principles of addiction risk assessment, identify specific types of pain and appropriate treatments for each, describe recent data regarding non-steroidal anti-inflammatory drugs and adjuvant analgesics in the treatment of chronic pain, describe therapeutic options for nonmalignant pain, discuss approaches to individualizing pain management, particularly in patients with issues such as high addiction risk or chronic nonmalignant pain, and identify administrative procedures to promote pain management in the context of regulatory environments.